Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipidose in Gram-negative Severe Sepsis
NCT00563134Phase 2Suspended
- Sponsor
- Hospital Authority
- Start
- Oct 2005
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of GR270773 in sepsis, Gram-negative bacterial infection, sponsored by Hospital Authority. Started Oct 2005; status: suspended.
02
Drugs
GR270773
03
Conditions
sepsisGram-negative bacterial infection
Beyond the preview
Go deeper on NCT00563134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563134.